QT
BCAB icon

Quantbot Technologies’s BioAtla BCAB Stock Holding History

Quantbot Technologies’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-97
Closed -$13K – 1578
2023
Q1 		$13K Buy
+97
New +$17.5K ﹤0.01% 1394
2022
Q3 		– Sell
-47
Closed -$6K – 1603
2022
Q2 		$6K Sell
47
-163
-78% -$25.9K ﹤0.01% 1570
2022
Q1 		$52K Buy
210
+124
+144% +$51.9K ﹤0.01% 1185
2021
Q4 		$84K Buy
+86
New +$110K 0.01% 910

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantbot Technologies's BCAB Position: Q2 2023 in Review

Quantbot Technologies sold out of BioAtla (BCAB) in Q2 2023, closing a stake of 97 shares — an estimated $13K sold.

Quantbot Technologies first reported a position in BCAB in Q4 2021 and held it in 4 quarters. The position peaked at $84K in Q4 2021. 87 funds tracked by Wall St. Rank hold BCAB as of Q2 2023.

  • Quantbot Technologies reported no remaining BioAtla position as of Q2 2023 after selling out during the quarter.
  • Quantbot Technologies sold 97 BioAtla shares in Q2 2023, an estimated $13K.
  • Quantbot Technologies first reported a position in BioAtla in Q4 2021 and held it in 4 quarters.
  • Quantbot Technologies's BioAtla position peaked at $84K in Q4 2021.
  • 87 funds tracked by Wall St. Rank held BioAtla as of Q2 2023.

Based on Quantbot Technologies's 13F filing for Q2 2023, filed 8 Aug 2023.